Abstract
Staging is of paramount importance in cancer management. In cervical carcinoma, it is performed using the clinical International Federation of Gynaecology and Obstetrics (FIGO) staging system. However, besides some inherent inaccuracies, it does not include important prognostic factors such as tumour size, which may help determine treatment strategies. These shortcomings of the clinical FIGO staging system underline the importance of accurate imaging evaluation of cervical carcinoma. Although magnetic resonance (MR) imaging is not officially incorporated into current staging work-up assessment, it has been shown by a number of studies to be the most reliable imaging modality in the evaluation of cervical cancer and in treatment planning. It has the advantages of direct tumour visualisation, accurate assessment of the depth of stromal invasion and tumour volume, and lymph node evaluation. In this article, the utility of MR imaging in the evaluation of cervical carcinoma is reviewed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
